OncoLink Cancer Treatment and Resources
Link to OncoLink

Information about Frey Syndrome

Li Liu, MD
Ultima Vez Modificado: 1 de noviembre del 2001

Question
Dear OncoLink "Ask the Experts,"
My husband recently had a surgery to remove cancer in his parotid gland. Ever since, he has been having problems with excessive sweating and flushing in his cheek and behind his ear. His doctor told him that this is Frey Syndrome and suggested surgery to cut his nerve. What exactly is Frey Syndrome? Are there any other treatments without cutting?  
Thank you.
D


Answer
Li Liu, MD, OncoLink editorial assistant, responds:

Dear D:
Thank you for your interest and question.

Frey syndrome, also called auriculotemporal nerve syndrome, was first described by Baillarger in 1853, and publicized by Frey in 1923 (Rev Neurol. 1923; 2:97-99). The syndrome usually manifests as immediate unilateral or, rarely, bilateral flushing and sweating in the cheek, behind the ears, and the temporal regions (distribution of the auriculotemporal nerve) after eating. Pain also can occur initially as a preliminary sign or can be the only symptom present. Typically, the symptoms occur several weeks or months after surgery. Frey syndrome is well recognized as a common complication of parotid surgery in adults and may also occur after nonsurgical trauma to the parotid gland region (Int J Dermatol 1986 Oct; 25(8): 524-6) or after suppurative parotiditis (Brain. 1948; 71:16-25.). The precise pathophysiology of Frey syndrome remains unknown.

To date, numerous methods have been used to treat patients with Frey syndrome. These methods have shown varying degrees of effectiveness and basically are divided into surgical methods and noninvasive drug treatments. The surgical methods involve excision of the affected areas of skin and the fasia or muscle. The literature also mentioned intracranial transection of the glossopharyngeal nerve (Münch med Wschr 1978; 27:120).

In recent years, various reports have documented the effectiveness of the intracutaneous injection of botulinum toxin type A in patients with Frey syndrome (J Neurol 1996 Feb; 243(2): 143-6; J Laryngol Otol 1997 Sep; 111(9): 839-44). Some studies reported 100% effectiveness and virtually no side effect with this type of treatment (Cancer 2000 Oct 15; 89(8): 1659-1663). Longer follow up is needed to evaluate long-term complication. You should discuss with your husband's doctors to explore different treatment options.

OncoLink I wish u knew...

Dr. Giantonio discusses the importance of oncology clinical trials and clarifies some myths about studies. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS